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ABSTRACT
The xyIR and xylS genes, which encode the positive
regulators of the TOL plasmid catabolic pathways, are
adjacent genes on the TOL plasmid and are transcribed
from divergent promoters. Transcription from the xylS
gene promoter, Ps, is positively regulated by effector-
activated XyIR protein and requires the specific RNA
polymerase sigma54 subunit (RpoN). Deletions and
point mutations in the Ps upstream region localized the
site of XyIR interaction to the region between - 133 bp
and - 207 bp (with respect to the transcriptional start
of the xylS messenger), which contains an inverted
sequence repeat largely homologous to the motif
recognised by XyIR in the XyIR-regulated 'upper'
catabolic pathway promoter, Pu. Gel retardation
experiments showed binding of IHF to the Ps promoter
region. Corresponding sequences showing good
homology to the IHF-binding consensus were identified
close to the Ps Promoter (between - 35 bp and - 47
bp, Ps proximal site) and further upstream overlapping
the XyIR recognition sequence (Ps distal site). In the
latter case IHF recognition motifs were found well
conserved on both strands at nearly the same position
(between -140 bp and -152 bp on the upper and
between - 141 bp and - 153 bp on the lower strand).
Expression from Ps, either under inducing or non-
inducing conditions, was, however, only slightly
influenced by the absence of IHF in an IHF-deficient
mutant and thus activation of Ps, like that of other
sigma54-dependent promoters which are rich in Ts,
does not absolutely require IHF protein.
INTRODUCTION
The Pseudomonas putida TOL plasmid contains four so-called
xyl gene operons that contain the genetic information required
for the degradation of toluene and related aromatic compounds.
The 'upper' and meta-pathway operons, expressed from the Pu
and Pm promoters, respectively, comprise the xyl structural genes
while the xylR and xylS genes, expressed from the Pr and Ps
promoters, respectively, encode the regulatory proteins of the
catabolic operons (1,2). xyl gene expression is controlled by a
regulatory cascade that is depicted in Figure 1: XylR protein
activated by pathway substrates (e.g. toluene, xylene, or 3-methyl
benzylalcohol =3MBA) and in concert with the RpoN sigma
factor activates transcription from the Pu and Ps promoters.
Hyperproduction of the XylS protein triggers transcription from
the meta-pathway promoter Pm such that coordinated synthesis
of the catabolic enzymes is achieved (3,4,5,6). The XylR protein
when activating transcription from Ps represses its own synthesis
from the Pr tandem promoters orientated away from the adjacent
Ps promoter (7,4).
Both the Pu and Ps promoters belong to a specific class of
promoters that is characterised by their dependance on a specific
RNA polymerase sigma factor, sigma54, encoded by the rpoN
gene. These promoters exhibit a well conserved consensus
sequence, namely 5'-TGG-Ng-TGCA-3', in the - 12,-24 bp
region (8,9,4,6). All promoters of this class require in addition
a specific activator protein, which usually binds 100 bp or more
upstream of its cognate promoter and which in its activated state
(activated by an appropriate environmental stimulus) promotes
transcription by interaction with the promoter-bound RNA
polymerase / sigma54 complex (10). Close proximity between
upstream bound activator and the promoter site is believed to
be brought about by DNA loop formation that often apparently
is aided by the binding of IHF protein at sites between the
promoter and upstream activator sequence (11).
Both Pu and Ps depend on sigma54 and are stimulated by
activated XylR protein. Activation of the XylR regulator is
believed to occur through the binding of one of a large variety
of activators (toluenes, benzylalcohols and related compounds;
12,13,7). Although a number of studies have been carried out
on the Pu promoter (14,15,16,17), little has so far been reported
on the Ps promoter. Here we present a functional analysis of
the Ps-Pr promoter region with respect to XylR and IHF protein
binding sites.
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Figure 1. Regulation of xvl gene operons. Black boxes denote
sigma54-dependent -24, - 12 type promoters, open boxes denote -35, - 10
standard type promoters; coding regions (not drawn to scale) are presented as
open arrows indicating the direction of transcription.
MATERIALS AND METHODS
Bacterial strains, plasmids and growth conditions
The Ecoli strains and plasmids that were used in the course of
this work are listed in Table 1. Relevant plasmid constructions
are described in the Results section. Strains were routinely grown
at 300C in LB with the appropriate antibiotics added at the
following concentrations (/tg/ml): ampicillin (100),
chloramphenicol (30), tetracycline (10), streptomycin (100),
nalidixic acid (20).
Enzyme assays
Transcription from the Ps and Pr promoters was measured in
Ecoli strains ET8000, S9OC or DPB101 carrying appropriate
promoter-lacZ fusion constructs. ,B-galactosidase was measured
according to Miller (18). Cultures were inoculated from
uninduced LB precultures and subsequently grown, with and
without 7.5 mM 3-methyl benzylalcohol for 16 hrs with vigorous
agitation.
DNA manipulations
For transformation of cells, transduction (Mini-Mulac
mutagenesis) and transfection (site-directed mutagenesis) standard
methods were applied, and preparation of plasmid DNA,
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Figure 2. A. Plasmid constructs. Vector names are given in brackets. For details of constructions see Results section in the text. B. Ps::IacZ fusion region
on plasmids pAH96, pAH97, pAH98 and pAH100. Fragments a, b, and c, used in the gel retardation assay, are indicated. The 0.6 kb BglII insert (marked
as a bold line) derives from TOL plasmid pWWO, the small box preceding the lacZ gene in the figure denotes a strong ribosome binding site (rbs). Restriction
sites: Ba=BamHI, Bg=BglII, Bst=BstEII, C=ClaI, E=EcoRI, H=HindIII, Hc=Hincll, S=SalI, Sm=Smal, Sp=SphI, St=StuI, X=XbaI, Xm=XmaI.
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restriction digests and separation of fragments from agarose gels
were essentially carried out as described previously (19).
Oligonucleotide site-directed mutagenesis
Point mutations were generated as described previously (20) using
mutant oligonucleotides and single stranded Ps promoter DNA
from plasmid pAH95. Plasmid pAH95 contains the Ps-Pr
promoter region on an EcoRI-XbaI fragment from pAH93 cloned
into the corresponding sites of plasmid pGC1 (21), a vector that
yields high amounts of single stranded DNA. Mutant
oligonucleotides were designed such that single base changes
simultaneously introduced new restriction sites; mutations were
thus easily verified by restriction analysis.
Deletions in the Ps promoter
Deletions were generated by successive removal of nucleotides
from the Stul site in the in the Ps promoter on plasmid pAH93
using exonucleaseIll / SI nuclease (22). Deletions endpoints were
determined by sequencing (23). Deletions from other restriction
sites resulting from the mutagenesis or already existing ones,
either blunt-ended or filled in with Klenow enzyme, were also
created (see Figures 2 and 3).
Gel mobility shift assay
End-labelled promoter fragments (0.1 to 10 ng, filled in with
nucleotides using Klenow enzyme and 32P dCTP and 32P dATP
as the labelled nucleotides) and purified IHF protein (10 ng IHF)
or IHF-buffer alone (without protein) were mixed in incubation
buffer (10% (w/v) glycerol, 50mM KCl, 5mM Tris pH 7.5,
1mM EDTA, 2mM MgCl2, 1mM CaCl2, 100 Ag/ml BSA) to
give a final volume of 20 1.l. Mixtures were incubated for 20
mins at 30°C. A 4% PAGE gel was prepared in TE Buffer
(20mM Tris pH 7.5, 5mM EDTA) and the samples were run
in the same TE buffer for 4 hs at 130 V in the cold (4°C). The
following fragments were used: a) the Ps promoter region up
to the SphI site at -87 bp (fragment a in Figure 2.B) on a 265
bp fragment with XmaI and HindIll ends (from SphI-deleted
plasmid pAH94), b) a 325 bp XmaI-HindIII fragment derived
from SphI-deleted plasmid pAH93, containing of the Ps promoter
only the upstream region beyond the above SphI site as well as
the complete Pr tandem promoter (fragment b in Figure 2.B),
and c) the entire Ps-Pr promoter region present on a 260 bp
BstEII-StuI fragment (fragment c in Figure 2.B) derived from
plasmid pAH93.
RESULTS
Construction of transcriptional and translational fusions of
Ps and Pr promoters to the lacZ reporter gene
A 0.6kb BglII fragment carrying the entire Ps and Pr promoter
region as well as small portions of the xylS and xylR coding
regions was excised from plasmid pRL38 (R.Leppik) and inserted
Table 1. Bacterial strains and plasmids
strain / source!
plasmid relevant characteristics reference
strains
E.coli
ET8000 rbs lacZ::ISI gyrA hutCr (38)
S90C (lac pro) rpsL (31)
DPB1I1 (lac pro) rpsL himD45 1 :mini-tet (31)
plasmids
pTZ19 cloning / sequencing vector, M13 origin Pharmacia
pGCI cloning / sequencing vector, M13 origin (21)
pBKI high copy number lacZ fusion vector, M13 origin B.Kessler
pMC14 03 intermediate copy number lacZ fusion vector (25)
pJEL122 low copy number lacZ fusion vector (24)
pRL38 xylR-xylS genes cloned into vector pBR322 R.Leppik
pTS 174 xylR gene cloned into vector pACYC 184 (39)
pAH90 Mini-Mulac translational xylS::lacZ fusion in plasmid pRL38 This work
pAH93 Ps-Pr promoter region cloned into pTZ19, <xylS> reading towards vector XbaI site
pAH94 as pAH93, but opposite orientation of insert, <xylR> reading towards XbaI site
pAH95 Ps-Pr promoter region cloned into pGC1, <xylS> reading towards XbaI site
pAH96 Ps-Pr promoter region cloned into pBK1, <xylS> reading towards vector lacZ gene, high copy number
pAH97 Ps::lacZ fusion region from pAH96 cloned into vector pMC1403, intermediate copy number
pAH98 as pAH97, but omega(Tcr) fragment cloned into EcoRI site upstream from insert
pAH100 Ps::lacZ fusion region from pAH96 cloned into vector pJEL122, low copy number
pAH101 as pAH100, but A-T mutation at -134 bp (upstream from Ps promoter), new EcoRV site
pAH 103 as pAH100, but T-C mutation at -141 bp (upstream from Ps promoter), new Bcll site
pAH104 as pAH 100, but T-C mutation at -145 bp (upstream from Ps promoter), new ClaI site
pAH106 as pAH100, but T-G mutation at -161 bp (upstream from Ps promoter), new HpaII site
pAHl1O as pAH 100, but deleted upstream from -218 bp (deleted upstream from StuI site)
pAHlll -207 bp ( HpaII site)
pAH112 -162 bp ( new HpaII site, see pAH106)
pAH1 13 -156 bp (deleted by ExonucleaseIII/Sl nuclease treatment)
pAH114 -154 bp ( ")
pAH1 15 -145 bp (deleted upstream from new ClaI site, see pAH 104)
pAH1 16 -142 bp (deleted by ExonucleaseIII/Sl nuclease treatment)
pAH1 17 -133 bp (deleted upstream from new EcoRV site, see pAH 101)
pAH1 18 -120 bp (deleted by ExonucleaseIII/SI nuclease treatment)
pAH 120 Pr::lacZ fusion on low copy vector pJEL122
1) for details of construction see Results section in the text.
1758 Nucleic Acids Research, Vol. 20, No. 7
extent of deletions
St s__ au3A
-1621
-1 45 F;
-142
-133
Ps::IacZ-w
fusion
construct
pAH 1 00
pAH110
pAH111
pAH112
pAHl 13
pAH 114
pAH115
pAH 116
pAH 117
pAH118
-120
8-galactosidase(units)
-3MBA +3MBA
150 2000
120 1780
110 1830
70 220
100 250
90 330
110 130
70 100
100 110
100 130
Figure 3. Activation of Ps promoter deletions. The inverted arrows indicate an inverted sequence repeat representing the site of interaction with XyIR activatorprotein. The extents of the deletions are marked in the figure. Abbreviations used for restriction sites are the same as in Figure 2.
into the BamHI site of the high copy sequencing vector pTZ19
to form pAH93 (Ps reading towards vector XbaI site, see
Figure 2.A) and pAH94 (opposite orientation). In construct
pAH93, the xylS reading frame reads into a stop codon located
within the vector XbaI site directly adjacent to the vector BamHI
site.
In order to construct an appropriate promoter-lacZ fusion vector
that would allow subcloning and measurement of the effects of
the promoter upstream deletions, the Ps promoter fragment was
excised from pAH93 as an EcoRI-HincH fragment and subcloned
into the EcoRI-SmaI sites of fusion vector pBK 1 (Figure 2.A),
which contains the entire lacZ gene preceded by a strong ribosome
binding site. However, due to its high copy number (about 80
per cell), this construct (pAH96) gives high uninduced basal levels
of ,B-galactosidase. A 1.7 kb EcoRI-ClaI fragment carrying the
promoter-lacZ fusion region was therefore subcloned into the
corresponding sites of the fusion vector pJEL122 (24) (1 copy
per cell), to form pAH100 (Figure 2.A and B). The same EcoRI-
ClaI fragment was also subcloned into the corresponding sites
of the intermediate copy number fusion vector pMC1403 (25),
to form pAH97 (about 30 copies per cell); since pAH97 still
exhibited high basal levels of ,B-galactosidase, a terminator-
containing omega fragment (Tcr) (26) was inserted into the
EcoRl site upstream of Ps on pAH97 in order to prevent potential
readthrough from the vector. This latter Ps: :lacZ fusion construct
was called pAH98 (Figure 2.A).
As all the above constructs represent transcriptional fusions,
a translational Ps xylS: :lacZ fusion was constructed to confirm
the validity of induction ratios of Ps as obtained from the
transcriptional fusion pAH100. To this end, plasmid
pRL38(Apr) containing the complete xylR-xylS region was
subjected to Mini-Mulac(Cmr) mutagenesis as described before
(27), and Ap- and Cm-resistant blue clones (blue upon induction
by 3MBA) were isolated that contain MiniMu inserted in xylS
(no induction of Pm anymore) and thus provide the desired
translational Ps: :lacZ fusion. One such clone was named pAH90.
A Pr: :lacZ transcriptional fusion plasmid was constructed as
follows: from plasmid pAH94, which differs from pAH93 only
by the orientation of the inserted BglII fragment, an EcoRI-XbaI
fragment carrying the insert was excised and cloned between the
corresponding sites of pAH100 to form plasmid pAH120(Figure 2.A). The resulting construct is identical to pAH100
except that the Bglll insert is inverted such that now the truncated
xylR gene (instead of xylS) reads towards lacZ.
Deletions and point mutations in the upstream region of the
xylS promoter
We have previously identified sequence homologies between Pu
and Ps in the region from - 120 to -210 bp upstream of the
main transcription initiation points (15). In order to define the
role of this region in the Ps promoter we generated a series of
deletions from the Stul site located at -218 bp. The wild type
promoter in pAH100 was substituted by the deleted promoters,
which were moved as EcoRI-XbaI fragments. 3-galactosidase
activity from wild type and deleted promoters was determined
in E.coli ET8000 also bearing plasmid pTS 174 (carrying the xylR
gene) in the presence and absence of 3-methyl benzylalcohol.
The extent of deletions as well as the corresponding /-
galactosidase activities are shown in Figure 3.
In the wild type, construct pAH100 containing the complete
Ps-Pr promoter region, an approximately 20-fold increase in
transcription from Ps was obtained upon induction by the XylR-
specific effector 3MBA. Similar induction levels were obtained
with the translational xylS::lacZ fusion pAH90.
Deletion constructs containing Ps upstream sequences up to
at least -207 bp, i.e. plasmids pAHl and pAHl 10, are as
well induced as the wild type; sequences beyond -207 bp are
thus not required for promoter activation. Further deletions up
to -162 bp, - 156 bp or -154 bp (constructs pAH l 12, pAH 13
and pAH 114, respectively), greatly reduced promoter activity,
though weak but significant activation (about 15% of induced
wild type activity) was still observed. Further deletions to - 145
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Figure 4. Relevant regions of the Ps promoter region. The inverted arrows denote an inverted sequence repeat as the putative site of interaction with XyIR pro-
tein; asterisks point out nucleotides that are conserved in the XylR-binding region of the Ps and Pu promoters; the two standard type (- 10, -35 type) Pr pro-
moters as well as the sigma54 dependent (- 12, -24 type) Ps promoter are marked out in the figure; the three dotted boxes indicate the IHF consensus sites.
upper strand -152 ARCCRATTGATTA -140
Ps distal sites ** ***----***
lower strand -1 41 ARTCARTTGGTTA -153
IHF consensus WATCAANtNNNTTR
** **----**
Ps proximal site -47 ARAGAACGTCTTC -35
Figure 5. Proposed IHF target sequences in Ps promoter proximal and distal
regions aligned to the IHF consensus sequence (W=A or T, N=any nucleotide,
and R=A or G; asterisks mark conserved nucleotides); all motifs presented
read in direction 5' to 3'.
bp and -120 bp (constructs pAH 115 to pAH1 18) completely
abolished activation. In summary, the region between - 133 bp
and -154 bp contains a sequence that mediates a limited
activation of Ps, whereas full promoter expression requires the
presence of a longer sequence extending to -207 bp.
Within this region, a number of bases were changed by site-
directed mutagenesis: the transitions A to T at -134 bp, T to
C at -141 bp, T to C at -145 bp and T to G at -161 bp all
created new restriction sites (EcoRV, BclI, ClaI and HpaII,
respectively; Figure 4). With the corresponding mutant Ps::lacZ
fusion constructs pAH101, pAH103 and pAH106, no obvious
difference in the induction pattern with respect to the wild type
was observed (Table 2). However, with the pAH 104 (T
- 145- C) construct a significant reduction (about 50%) in basal
and maximum levels was found, although the induction ratio (fi-
galactosidase activity in the presence of effector / ,B-galactosidase
activity in the absence of effector) was similar to that in the wild
type Ps promoter (see Discussion).
Ps and Pr promoter activation in a mutant strain deficient
in IHF protein
In this paper we report two regions within the Pr/Ps-promoter
region (Figures 4 and 5) that bind IHF protein. One of these,
the Ps proximal site (between -35 bp and -47 bp), corresponds
to a site that based on sequence homologies we had already
predicted in an earlier report (15). The second region (the Ps
distal site) in fact comprises two highly conserved IHF consensus
sequences (for IHF consensus see refs. 28,29,30) present on the
upper (8 out of 9 residues conserved) and on the lower strand
(9 out of 9 residues conserved) differing in position by only one
nucleotide. These latter (distal) sites are located further upstream
Table 2. Activation of mutant Ps promoter constructs
,B-galactosidase
(units)
construct characteristics -3MBA +3MBA
pAH 100 wildtype Ps promoter region 150 2000
pAHIOI A-T transition at - 134 bp 140 1650
pAH 103 T-C " -141 bp 120 1960
pAH104 T-C " -145 bp 90 880
pAH106 T-G " -161 bp 140 1980
,3-galactosidase activity from Ps: :lacZ fusion constructs was measured in E.coli
ET8000 harbouring pTS174 (xyIR); 7.5mM 3MBA were added for induction;
experimental details are given in the Materials and Methods section.
Table 3. Activation of Ps and Pr promoters in IHF proficient and IHF deficient
strains
f-galactosidase
IHFfusion characteristics (units)
construct -MBA +MBA
+ pAH100 Ps::lacZ fusion, 1 copy 190 2360
290 1990
+ pAH 104 as pAH 100, but point mutation 70 820
in XylR-binding site
140 410
+ pAH98 Ps::lacZ fusion, 30 copies 510 4690
1020 2460
+ pAH120 Pr::lacZ fusion, 1 copy 490 330
450 330
Measurements of ,B-galactosidase activities were carried out as described in the
Materials and Methods section; both the IHF-proficient strain (S9OC, '+' in
the table) and the IHF-deficient strain (DPB1O1, '-' in the table) carried in addition
to the respective Ps promoter fusion construct plasmid pTS174 providing XylR
activator protein.
within the region required for XylR-mediated activation of Ps,
thereby also overlapping part of the Pr tandem promoters.
We therefore examined expression from both Ps and Pr
promoters in isogenic IHF-minus and IHF-plus strains (bearing
xylR on pTS174) with and without 3-methyl benzylalcohol (Table
3). The low copy plasmids pAH100 and its mutant derivative
pAH104 were used to monitor activation of Ps in the IHF plus
and minus backgrounds. pAH 104 carries the point mutation that
caused a decrease of Ps promoter activity. Our results show that
a lack of IHF protein reduced activation of Ps by 3MBA/XylR
.... .TACGGGCTGTCGTGCTTGAI
_A7
-1
I .
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Figure 6. Gel retardation of promoter fragments by IHF protein. Identical
incubation mixtures containing the respective fragments were incubated with IHF-
free buffer ('-' samples) or with 10 ng IHF protein in the same buffer ('+'
samples). For further details on incubation and electrophoresis conditions see
Material and Methods section. Lanes A: Ps proximal promoter fragment a
(containing Ps promoter); lanes B: Ps distal promoter fragment b (containing Pr
tandem promoter); lanes C: Ps-Pr promoter fragment c (containing the entire
Ps and Pr promoter region).
by 20-30%, which is by far not as much as the respective
decrease observed for the Pu promoter (70% reduction; 14,17).
Moreover, basal expression from Ps (i.e. in the absence of
effector) is higher in the IHF minus background. This pattern
of activation was similar for the wild type construct pAH 100 and
the mutant promoter pAH 104, although activity levels obtained
with pAH104 were in all cases by about 50% lower than those
obtained with pAH100. To confirm the suggestion that IHF may
be involved in 'repression' of Ps under non-inducing conditions
we used a fusion in the intermediate copy number plasmid
pAH98: here basal ,B-galactosidase levels in the absence of
effector were 500 units in the IHF plus background, while they
were twice as high in the IHF minus strain, which clearly reflects
some involvement of IHF protein in Ps regulation (see Discussion
section).
The xylR gene promoter Pr is transcribed divergently from the
adjacent Ps promoter. It has been reported that Pr is slightly
repressed in the presence of inducer (4,7). This XylR/effector-
mediated 'autoregulation' was observed for the Pr: :lacZ fusion
in pAH120 in both the IHF wild type and mutant background
(Table 3). Therefore, IHF protein does not seem to be involved
in the expression of the Pr promoter.
Gel retardation by IHF protein of fragments carrying distinct
parts of the Ps-Pr promoter region
Since two putative regions of IHF binding were found in the Ps-
Pr promoter region (in one case with the IHF consensus motif
well conserved at almost the same position on both strands), the
Ps-Pr promoter region was split into the two fragments described
in Materials and Methods (see also Figure 2.B). One fragment
(fragment a) contains the Ps promoter up to -87 bp and thus
carries one IHF site (Ps proximal site), whereas the other
(fragment b) extends from -87 bp further upstream and thereby
includes the second (Ps distal) IHF binding region (with the IHF
consensus on both strands) and the Pr tandem promoters. A
fragment carrying both the entire Ps and Pr promoter regions
(fragment c) was also tested. Figure 6 shows that both the Ps
promoter fragment a (lanes A) and the Ps promoter upstream
Pr promoter fragment b (lanes B) were retarded by added IHF
protein, as was fragment c bearing both these regions together
(lanes C). Similar IHF-dependent shifts of the distinct Ps promoter
fragments were also obtained with crude extracts from a strain
bearing a plasmid with the IHF-encoding genes under the control
of the IPTG-inducible ptac promoter: here fragment shifts were
observed only with crude extracts prepared from IPTG-induced,
i.e. IHF-producing cultures (data not shown).
DISCUSSION
We reported earlier that XylR-mediated activation of both the
Pu and Ps promoters requires promoter upstream sequences (15),
in the case of Ps confined to a stretch between - 118 bp (Sau3A
site, Figure 3) and -218 bp (Stul site). Based on sequence
homologies between the Pu and Ps promoter upstream sequences
a small potential XylR-binding motif was deduced which appears
twice in both promoters.
Recently, deletion and insertion studies on the Pu promoter
(14,16) as well as complementing DNA-protection experiments
(14,17) identified a rather large inverted sequence repeat between
- 127 bp and - 172 bp upstream of the Pu promoter as the site
of binding of the XylR activator protein, and this motif comprises
the earlier suggested smaller motifs. A rather large inverted repeat
sequence homologous to the region protected by XylR protein
in the Pu promoter was also found in the Ps promoter between
- 136 bp and - 187 bp (16) (Figure 4) comprising the region
that contains the two previously identified smaller motifs. The
results presented here suggest that the above proposed larger
inverted repeat sequence motif represents the XylR-binding region
within the Ps promoter: deletions further upstream that do not
overlap the outlined motif (Figures 3 and 4) do not affect
activation of Ps; removal of only the upper half of the inverted
repeat reduces induction but does not abolish it entirely, whereas
deletions that also remove partly or completely the downstream
half of the repeat, totally prevent activation of the Ps promoter.
Consistent with this was the finding, that from the 4 single point
mutations generated in the Ps promoter only construct pAH 104,
where a conserved base within the inverted repeat region of Ps
and Pu was changed, exhibited reduced basal and maximum levels
of transcriptional activation of Ps. It has been reported for the
Pu promoter that both in vivo (14) and in vitro (17) XylR binds
to its recognition sequence to some extent also in the absence
of effector. Therefore, a mutation in the XylR recognition motif
is expected to diminuish both basal and maximum levels of
promoter activation, as it was observed here for mutant construct
pAH104. A similar decrease of Ps activity is found when
measuring transcription from Ps in a strain devoid of XylR protein
(about 80 units of 3-galactosidase, not shown). Mutations either
of conserved bases just outside of the repeat regions (constructs
pAHIOI and pAH106) or of a non-conserved base within one
arm of the repeat (pAH103) did not have any deleterious effect
on Ps promoter activation. Thus, our data indicate that XylR
activator protein recognizes the two halves of the proposed motif
in the Ps promoter upstream region, as it does in the Pu promoter.
Removal of only one half of the inverted repeat appears to allow
recognition of the remaining half by XylR protein, thus permitting
weak binding of XylR and a corresponding weak XylR-mediated
induction of Ps. At present it is not clear whether the two halves
of the inverted repeat are contacted by two subunits of one dimeric
XylR molecule or by two individual XylR molecules. In the latter
case, since binding to only one site permits only weak activation
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whereas binding to both sides gives a much greater induction,
cooperative binding of XylR would be likely.
We suggested previously the existence of potential IHF binding
sites in the Pu and Ps promoters (15) and this has now been
confirmed with the Pu promoter (14,17). In the present study
we have identified by gel retardation assays two regions upstream
of Ps that bind IHF and which exhibit good IHF consensus
sequences: one site preceding the Ps promoter between -35 bp
and -47 bp, we had already predicted in our previous report
(15); two more sites were located further upstream at almost the
same position but in opposite orientation on either of the opposing
strands; these sites precede the Pr promoter and overlap part of
the identified XylR-binding site (Figures 4 and 5). Since rather
high concentrations (about 5 /Ag/ml) of IHF protein had to be
applied both in our experiments and a previous study by de
Lorenzo (17) and since the retarded bands displayed considerable
smearing, we conclude that binding of IHF to the two regions
in the Ps promoter region is rather weak. Such weak interaction
of IHF with the Ps-Pr promoter region corresponds to the results
obtained for the induction of Ps::lacZ and Pr::lacZ fusions in
IHF-deficient and -proficient strains (Table 3). In IHF wild type
strain S90C, under non-inducing conditions the relatively weak
binding of IHF to the Ps distal site overlapping part of the XylR-
binding motif may suffice to prevent uninduced XylR protein
from binding and thus ensures complete 'repression' of Ps. Under
inducing conditions, activated XylR protein binds strongly to its
recognition sequence and is not notably affected by IHF which
competes only weakly for part of the sequence. In the IHF-
deficient strain DPB101, slightly impaired activation of Ps was
observed. It may be assumed that IHF normally functions on the
Ps proximal IHF-binding site by stabilizing bends or loop
structures to favour good activation of Ps; lack of IHF thus could
cause a small decrease of activation. It can be excluded that lack
of IHF indirectly affects activation of Ps via decreased expression
of XylR activator protein: the results for the Pr fusion construct
pAH 120 in Table 3 show that expression of the xylR gene
promoter Pr is not at all impaired in the IHF-deficient strain.
On the other hand, at the present stage it cannot be excluded that
lack of IHF may indirectly alter transcription from Ps via reduced
levels of DNA gyrase activity (31,32).
It appears that quite generally those sigma54-dependent
promoters which, like Ps, are rich in Ts, do not absolutely require
IHF protein for activation (37), probably because the required
bend in the DNA is attained by the T-rich stretch of sequence
itself. Our observations underline once more the notion that IHF
exerts primarily structural rather than regulatory functions: while
DNA-bending brought about by IHF protein often aids promoter
activation as it is the case e.g. for the Pu, KpnijH or Caulobacter
flagellar promoters (14,17,33,29), examples of negative effects
of IHF on promoter activation under certain circumstances or
on specific promoter activator-binding sites have also been
described, e.g. for the EcompC and ompB, the KpniJV, or the
EcglnHp2 promoters (34,35,36,37) and here for the Ps promoter
distal IHF sites overlapping the XylR-binding region. Thus,
whereas XylR-mediated activation of both the Pu and Ps
promoters is effected in exactly the same manner, the involvement
of IHF protein apparently is of a different nature in the two
promoters: in Pu (poor in Ts) IHF is absolutely essential for
XylR-mediated induction; in Ps (rich in Ts) lack of IHF results
only in slightly reduced activation of Ps upon induction and
somewhat incomplete 'repression' of transcription under non-
inducing conditions.
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